Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.
about
One level up: abnormal proteolytic regulation of IGF activity plays a role in human pathophysiologyNovel Modulators of the Growth Hormone - Insulin-Like Growth Factor Axis: Pregnancy-Associated Plasma Protein-A2 and Stanniocalcin-2.Pharmacokinetics of IGF-1 in PAPP-A2-Deficient Patients, Growth Response, and Effects on Glucose and Bone Density.Insulin-like growth factors: actions on the skeleton.
P2860
Treatment With Recombinant Human Insulin-Like Growth Factor-1 Improves Growth in Patients With PAPP-A2 Deficiency.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@en
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@nl
type
label
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@en
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@nl
prefLabel
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@en
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@nl
P2093
P2860
P50
P356
P1476
Treatment With Recombinant Hum ...... ients With PAPP-A2 Deficiency.
@en
P2093
Andrew Dauber
Federico Hawkins
Horacio M Domené
Jan Frystyk
Jesús Argente
Jesús Pozo
Luis A Pérez-Jurado
María T Muñoz-Calvo
Ron G Rosenfeld
Shoshana Yakar
P2860
P304
P356
10.1210/JC.2016-2751
P407
P577
2016-09-20T00:00:00Z